Feature CellAegis to complete enrolment in U.S. autoRIC trial by end of 2018 By Len Zehrs In addition to several large ongoing investigator-sponsored studies in Europe and Canada using its autoRIC device for automated remote ischemic conditioning (RIC), closely-held CellAegis Devices expects its... May 8, 2018